| 英文名稱 |
中文名稱 |
CAS號 |
操作 |
| Ophiobolin B |
蛇孢菌素B |
5601-74-1 |
詳細
|
| Erdosteine |
厄多司坦 |
84611-23-4 |
詳細
|
| O-Methyl Atorvastatin hemicalcium |
阿托伐他汀EP雜質(zhì)G |
887196-29-4 |
詳細
|
| ORM-10103 |
ORM-10103 |
488847-28-5 |
詳細
|
| Ilginatinib maleate |
1354799-87-3 |
1354799-87-3 |
詳細
|
| Olcegepant hydrochloride；BIBN-4096 hydrochloride;BIBN4096BS hydrochloride |
586368-06-1 |
586368-06-1 |
詳細
|
| Oxidopamine hydrochloride |
6-羥基多巴胺鹽酸鹽 |
28094-15-7 |
詳細
|
| Orelabrutinib |
奧布替尼 |
1655504-04-3 |
詳細
|
| Opioid receptor modulator 1 |
OPIOID RECEPTOR MODULATOR 1 |
77514-44-4 |
詳細
|
| Oral antiplatelet agent 1 |
ORAL ANTIPLATELET AGENT 1 |
2299200-91-0 |
詳細
|
| Cefuroxime axetil |
頭孢呋辛酯 |
64544-07-6 |
詳細
|
| OR-1896 |
左西孟旦雜質(zhì) |
220246-81-1 |
詳細
|
| NSP-805 |
125068-54-4 |
125068-54-4 |
詳細
|
| Org30958 |
19-(ethyldithio)androst-4-ene-3,17-dione |
99957-90-1 |
詳細
|
| Olmesartan-d4；RNH-6270 D4;Olmesartan D4 |
奧美沙坦酯-D4 |
1420880-41-6 |
詳細
|
| OMDM-1；(Z)-N-[(2S)-1-hydroxy-3-(4-hydroxyphenyl)propan-2-yl]octadec-9-enamide |
OMDM-1 |
616884-62-9 |
詳細
|
| Ilginatinib hydrochloride |
化合物 Ilginatinib hydrochloride |
1239358-85-0 |
詳細
|
| OP-1074 |
OP-1074 |
1443752-76-8 |
詳細
|
| Oleoylethanolamide |
油酰單乙醇胺 |
111-58-0 |
詳細
|
| OMDM-6 |
OMDM-6 |
616884-67-4 |
詳細
|
| Oxythiamine diphosphate |
Oxythiamine diphosphate |
10497-04-8 |
詳細
|
| Benzquinamide；BZQ;Benzoquinamide;P2647 |
苯喹胺 |
63-12-7 |
詳細
|
| p53 and MDM2 proteins-interaction-inhibitor (chiral)；p53-and-mdm2-proteins-interaction-inhibitor-chiral |
2-[4-[[(4S,5R)-4,5-雙(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧苯基]-4,5-二氫-4,5-二甲基-1H-咪唑-1-基]羰基]-1-哌嗪基]-1-(4-嗎啡啉)乙酮 |
939981-37-0 |
詳細
|
| Omeprazole-d3；H 16868 D3;Omeprazole D3 |
奧美拉唑-D3 |
922731-01-9 |
詳細
|
| Oxidopamine hydrobromide |
6-羥基多巴胺氫溴酸鹽 |
636-00-0 |
詳細
|
| NSC305787 |
785718-37-8 |
785718-37-8 |
詳細
|
| NSC305787 hydrochloride |
NSC305787 HYDROCHLORIDE |
53868-26-1 |
詳細
|
| Pamabrom |
帕馬溴 |
606-04-2 |
詳細
|
| Ebopiprant |
OBE022 |
2005486-31-5 |
詳細
|
| Oleanolic acid hemiphthalate disodium salt |
Olean-12-en-28-oic acid, 3-[(2-carboxybenzoyl)oxy]-, sodium salt (1:2), (3β)- |
168770-31-8 |
詳細
|
| OMDM-3 |
OMDM-3 |
616884-64-1 |
詳細
|
| OSMI-3 |
OSMI-3 |
2260791-13-5 |
詳細
|
| Olcegepant |
N-[2-[5-氨基-1(S)-[4-(4-吡啶基)哌嗪-1-甲酰基]戊基氨基]-1(R)-(3,5-二溴-4-羥基芐基)-2-氧代乙基]-4-(2-氧代-1,2,3,4-四氫喹唑啉-3-基)哌啶-1-甲酰胺 |
204697-65-4 |
詳細
|
| Obtusifoliol |
鈍葉醇 |
16910-32-0 |
詳細
|
| Benzyl-α-GalNAc |
芐基-2-乙酰胺基-2-脫氧-Α-D-吡喃半乳糖苷 |
3554-93-6 |
詳細
|
| Oleuropeinic acid |
橄欖苦苷酸 |
96382-90-0 |
詳細
|
| ORM-15341 |
ORM-15341 |
1297537-33-7 |
詳細
|
| 5,5-Dimethyloxazolidine-2,4-dione |
5,5-二甲基噁唑烷-2,4-二酮 |
695-53-4 |
詳細
|
| OTS186935 |
OTS186935 |
2093400-18-9 |
詳細
|
| Oxaquin；MCB-3837;DNV3837 |
MCB-3837 |
790704-50-6 |
詳細
|
| Siremadlin (R Enantiomer)；HDM201 R Enantiomer;NVP-HDM201 R Enantiomer;Siremadlin R Enantiomer |
NVP-HDM201 R-ISOMER |
1448867-42-2 |
詳細
|
| CBP/p300-IN-5；P300/CBP-IN-5 |
P300/CBP-IN-5 |
1889284-33-6 |
詳細
|
| Mepyramine maleate |
N-[(4-甲氧苯基)甲基]-N-(2-吡啶基)-N’,N’-二甲基-乙二胺馬來酸鹽 |
59-33-6 |
詳細
|
| Fludazonium chloride |
FLUDAZONIUM CHLORIDE |
53597-28-7 |
詳細
|
| Pilocarpine nitrate |
硝酸毛果蕓香堿 |
148-72-1 |
詳細
|
| NVP-QAV-572 |
N-[2-[2-(2-氟乙基)-2H-四唑-5-基]乙基]-N'-[5-[3-氟-4-(甲基磺?；?苯基]-4-甲基-2-噻唑基]脲 |
957209-68-6 |
詳細
|
| Olaparib-d5；Olaparib D5;KU0059436 D5;AZD2281 D5 |
Olaparib D5 |
2143107-56-4 |
詳細
|
| Oligomycin C |
寡霉素C |
11052-72-5 |
詳細
|
| NXT629 |
NXT629 |
1454925-59-7 |
詳細
|
| ORM-10962 |
1-Piperidineacetamide, N-[6-[(3,4-dihydro-2-phenyl-2H-1-benzopyran-6-yl)oxy]-3-pyridinyl]-4-hydroxy- |
763926-98-3 |
詳細
|
| OT antagonist 3 |
OT ANTAGONIST 3 |
925703-75-9 |
詳細
|
| ODM-204 |
ODM-204 |
1642818-64-1 |
詳細
|
| Lincomycin hydrochloride monohydrate |
鹽酸林可霉素(一水物) |
7179-49-9 |
詳細
|
| NVS-CRF38 |
1207258-55-6 |
1207258-55-6 |
詳細
|
| Olanzapine D3；LY170053 D3 |
奧氮平-D3 |
786686-79-1 |
詳細
|
| OSMI-4 |
OSMI-4 |
2260791-14-6 |
詳細
|
| OXFBD04 |
OXFBD04 |
2231747-03-6 |
詳細
|
| NTP42 |
NTP-42 |
2055599-51-2 |
詳細
|
| OMDM-4 |
OMDM-4 |
616884-65-2 |
詳細
|
| OT-82 |
OT-82 |
1800487-55-1 |
詳細
|
| Odapipam；NNC 756 |
奧達匹泮 |
131796-63-9 |
詳細
|
| OT-R antagonist 1；Oxytocin receptor antagonist 1 |
化合物 T12331L |
364071-17-0 |
詳細
|
| Oligomycin B |
寡霉素B |
11050-94-5 |
詳細
|
| Oxotremorine M iodide |
Oxotremorine M |
3854-04-4 |
詳細
|
| Oxythiamine；Hydroxythiamin |
OXYTHIAMINE HYDROCHLORIDE |
136-16-3 |
詳細
|
| OMDM-2 |
OMDM-2 |
616884-63-0 |
詳細
|
| ARRY-797 |
P38Α INHIBITOR 1 |
1034189-82-6 |
詳細
|
| P-gp inhibitor 1 |
P-GP INHIBITOR 1 |
2050747-49-2 |
詳細
|
| CBP/p300-IN-3 |
P300/CBP-IN-3 |
2299226-01-8 |
詳細
|
| Cefonicid sodium；Monocid sodium;Cefonicid disodium salt |
頭孢尼西鈉 |
61270-78-8 |
詳細
|
| Palbinone |
芍藥二酮 |
139954-00-0 |
詳細
|
| Ornidazole (Levo-) |
左旋奧硝唑 |
166734-83-4 |
詳細
|
| O-Desmethyl apixaban |
1-(4-羥基苯基)-7-氧代-6-[4-(2-氧代哌啶-1-基)苯基]-4,5,6,7-四氫-1H-吡唑并[3,4-C]吡啶-3-甲酰胺 |
503612-76-8 |
詳細
|
| NSC624206 |
NSC-624206 |
13116-77-3 |
詳細
|
| p38-α MAPK-IN-1 |
443913-15-3 |
443913-15-3 |
詳細
|
| OICR-0547 |
1801873-49-3 |
1801873-49-3 |
詳細
|
| ORL1 antagonist 1 |
ORL1 antagonist 1 |
1174985-59-1 |
詳細
|
| OM-189 |
OM-189 |
55381-18-5 |
詳細
|
| NVS-ZP7-4 |
NVS-ZP7-4 |
2349367-89-9 |
詳細
|
| Oleoylcarnitine |
(R)-oleoylcarnitine |
38677-66-6 |
詳細
|
| OT antagonist 1 |
OT antagonist 1 |
479080-38-1 |
詳細
|
| P-gp modulator 1 |
P-gp modulator 1 |
2249749-39-9 |
詳細
|
| O-Desmethyl Midostaurin；O-Desmethyl PKC412;CGP62221 |
Benzamide, N-[(9S,10R,11R,13R)-2,3,10,11,12,13-hexahydro-10-hydroxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3',2',1'-lm]pyrrolo[3,4-j][1,7]benzodiazonin-11-yl]-N-methyl- |
740816-86-8 |
詳細
|
| NV-5138 |
Pentanoic acid, 2-amino-5,5-difluoro-4,4-dimethyl-, (2S)- |
2095886-80-7 |
詳細
|
| Orotic acid-6-C14 |
OROTIC ACID-6-C14 |
13186-54-4 |
詳細
|
| Oxolinic acid |
惡喹酸 |
14698-29-4 |
詳細
|
| O-Propargyl-Puromycin |
1416561-90-4 |
1416561-90-4 |
詳細
|
| ON 146040 |
1404231-34-0 |
1404231-34-0 |
詳細
|
| Ilginatinib |
化合物ILGINATINIB |
1239358-86-1 |
詳細
|
| Omeprazole metabolite Omeprazole sulfone |
奧美拉唑雜質(zhì)A |
88546-55-8 |
詳細
|
| OMDM-5 |
OMDM-5 |
616884-66-3 |
詳細
|
| OTS186935 trihydrochloride |
OTS186935 trihydrochloride |
2093401-85-3 |
詳細
|
| Org-10490 |
6,7,8,9-tetrahydro-7-methyl-5H-dibenz[b,i][1,6]oxazecine |
83507-02-2 |
詳細
|
| p53 and MDM2 proteins-interaction-inhibitor (racemic)；p53-and-mdm2-proteins-interaction-inhibitor-racemic |
REL-2-[4-[[(4R,5S)-4,5-雙(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧基苯基]-4,5-二氫-4,5-二甲基-1H-咪唑-1-基]羰基]-1-哌嗪基]-1-(4-嗎啉基)乙酮 |
939983-14-9 |
詳細
|
| OT-R antagonist 2；Oxytocin receptor antagonist 2 |
364071-16-9 |
364071-16-9 |
詳細
|
| Tirabrutinib hydrochloride |
ONO-4059 (HYDROCHLORIDE) |
1439901-97-9 |
詳細
|
| NVP-CGM097 sulfate；CGM097 sulfate |
1313367-56-4 |
1313367-56-4 |
詳細
|
| Octadecanedioic acid |
十八烷二酸 |
871-70-5 |
詳細
|
| NUCC-390 |
化合物 T12269 |
1060524-97-1 |
詳細
|
| OSMI-2 |
OSMI-2 |
2260542-60-5 |
詳細
|